← Open Payments lookup

PAUL SADAMA: Open Payments

NPI 1609452077 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,090 in 16 payments from 7 companies in 2025. Trend: 2023 $511 · 2024 $1,030 · 2025 $3,090

Consulting: $2,588Food & beverage: $503
CompanyPaymentsAmount
Janssen Biotech, Inc.3$2,750
Stemline Therapeutics Inc.4$104
Novartis Pharmaceuticals Corporation3$68
TerSera Therapeutics LLC2$61
Merck Sharp & Dohme LLC2$44
AstraZeneca Pharmaceuticals LP1$32
JAZZ PHARMACEUTICALS INC.1$31

Products named: RYBREVANT, Orserdu, KISQALI, Zoladex, KEYTRUDA, ENHERTU, ZEPZELCA.

Industry payments across NY — which companies pay providers there.